OCT 06, 2020 11:26 PM PDT

Drug For A Severe E. Coli Infection

WRITTEN BY: Nouran Amin

Escherichia coli, known as E. coli, is a popular bacterium associated with food poisoning and depending on the strain can cause enterohemorrhagic E. coli (EHEC).

EHEC is a severe infection that affects the brain and kidneys via the release of Shiga toxins. To combat the infection, researchers discovered a new molecular pathway that can be the basis of a therapeutic. The study comes especially critical as there are no commercially available treatments for the infection.

"Antibiotic treatment of these infections is generally not recommended because antibiotics stimulate production of the Shiga toxin, leading to an increased risk of kidney failure, neurological damage, and death," says Dr. Jai Tree, the study's senior author.

Learn more about E. coli:

Findings were published this week in the Proceedings of the National Academy of Sciences.

"The new pathway that we have found reduces toxin production and is not expected to be stimulated by antibiotic treatment. So, our results identify a potential new target for the development of drugs that can suppress Shiga toxin production during EHEC infection.

"It's still early days, however, and we need to conduct a lot more research to understand if our findings apply to a broad range of clinical EHEC isolates and to both types of Shiga toxins produced by human EHEC isolates."

Source: Science Daily

About the Author
Master's (MA/MS/Other)
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
NOV 30, 2022
Cannabis Sciences
Losing weight with cannabis
Losing weight with cannabis
Is it possible to lose weight with cannabis? Here's what the latest research tells us.
DEC 18, 2022
Drug Discovery & Development
Activated Vitamin D3 May Protect Against Arsenic in Drinking Water
Activated Vitamin D3 May Protect Against Arsenic in Drinking Water
Activated vitamin D3 may protect against various conditions- including skin cancer- that arise after drinking arsenic-co ...
DEC 19, 2022
Cancer
TIL Therapy for Advanced Melanoma Extends Survival Over Ipilimumab
TIL Therapy for Advanced Melanoma Extends Survival Over Ipilimumab
Immune checkpoint inhibitors (ICIs) have become a treatment option for many patients with advanced melanoma.  Still ...
DEC 24, 2022
Drug Discovery & Development
New drug discovery program powered by AI for oncology indication
New drug discovery program powered by AI for oncology indication
XtalPi is a quantum-physics, AI-powered Research and Development company based in Cambridge, MA, with branches in China. ...
JAN 05, 2023
Cancer
Unraveling the link between cancer and circadian rhythm
Unraveling the link between cancer and circadian rhythm
All organisms have a circadian rhythm. In plants, for example, circadian rhythm helps sense light, temperature, length o ...
JAN 04, 2023
Clinical & Molecular DX
Dual-Action Cancer Vaccine Targets Brain Tumors Directly
Dual-Action Cancer Vaccine Targets Brain Tumors Directly
Scientists have developed a new, targeted strategy to eliminate brain tumors and prevent future recurrences of brain can ...
Loading Comments...